Technical Analysis for TSBX - Turnstone Biologics Corp.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | -0.76% | |
| NR7 | Range Contraction | -0.76% | |
| Narrow Range Bar | Range Contraction | -0.76% | |
| Inside Day | Range Contraction | -0.76% | |
| Oversold Stochastic | Weakness | -0.76% | |
| Stochastic Buy Signal | Bullish | -0.76% | |
| Bollinger Band Squeeze | Range Contraction | -0.76% |
| Alert | Time |
|---|---|
| Down 2 % | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
| 10 DMA Resistance | 2 days ago |
| 1.5x Volume Pace | 2 days ago |
| Up 1% | 2 days ago |
Get a Trading Assistant
- Earnings date: 02/28/2024
Turnstone Biologics Corp. Description
Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to TIL therapy. Turnstone’s innovative TIL therapy is based upon the identification, selection, and expansion of the most potent tumor-reactive T cells, known as Selected TILs, and is designed to overcome the limitations of first-generation bulk TILs that have demonstrated objective responses only in limited tumor types. Turnstone’s most advanced program, TIDAL-01, is currently being evaluated in two Phase 1 studies in patients with melanoma, breast cancer, and colorectal cancer, and the Company is also actively advancing its preclinical pipeline programs including TIDAL-02, its next Selected TIL program, and its TIDAL-01 and viral immunotherapy combination program.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Solid Tumors Immunotherapy Breast Cancer Melanoma Colorectal Cancer Tumor Infiltrating Lymphocytes
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.2 |
| 52 Week Low | 1.625 |
| Average Volume | 163,849 |
| 200-Day Moving Average | 3.50 |
| 50-Day Moving Average | 2.89 |
| 20-Day Moving Average | 2.82 |
| 10-Day Moving Average | 2.68 |
| Average True Range | 0.26 |
| RSI (14) | 43.50 |
| ADX | 13.21 |
| +DI | 13.60 |
| -DI | 20.28 |
| Chandelier Exit (Long, 3 ATRs) | 2.62 |
| Chandelier Exit (Short, 3 ATRs) | 3.28 |
| Upper Bollinger Bands | 3.21 |
| Lower Bollinger Band | 2.42 |
| Percent B (%b) | 0.24 |
| BandWidth | 27.78 |
| MACD Line | -0.08 |
| MACD Signal Line | -0.07 |
| MACD Histogram | -0.015 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.79 | ||||
| Resistance 3 (R3) | 2.79 | 2.74 | 2.76 | ||
| Resistance 2 (R2) | 2.74 | 2.69 | 2.74 | 2.75 | |
| Resistance 1 (R1) | 2.67 | 2.66 | 2.71 | 2.67 | 2.74 |
| Pivot Point | 2.62 | 2.62 | 2.63 | 2.62 | 2.62 |
| Support 1 (S1) | 2.55 | 2.57 | 2.59 | 2.55 | 2.48 |
| Support 2 (S2) | 2.50 | 2.54 | 2.50 | 2.47 | |
| Support 3 (S3) | 2.43 | 2.50 | 2.46 | ||
| Support 4 (S4) | 2.43 |
